WHO grade (P = 0.7), tumor location (P = 0.5), tumor size (P = 0.2), NF‐1 status (P = 0.6) and the applied tailored treatment strategy (P = 0.8) did not gain prognostic influence. This evidence concerns the gene NF1 and neoplasm.